The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy.

Chenjing ZhuOtilia MenyhartBalázs GyőrffyXia He

Published in: BMC cancer (2019)

SPAG5 could be used as an independent prognostic and predictive biomarker that might have clinical utility, especially in ER+ breast cancer patients who received hormonal therapy.

Keyphrases

gene expression
dna methylation
type diabetes
stem cells
polycystic ovary syndrome
mesenchymal stem cells
adipose tissue
replacement therapy